# Phase 1 Study in Healthy Subjects to Evaluate the Effect of Rifampin on the Pharmacokinetics of IPI-145

> **NCT01947777** · PHASE1 · COMPLETED · sponsor: **SecuraBio** · enrollment: 14 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** IPI-145
- **DRUG:** Rifampin

## Key facts

- **NCT ID:** NCT01947777
- **Lead sponsor:** SecuraBio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2013-11
- **Final completion:** 2013-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2021-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01947777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01947777, "Phase 1 Study in Healthy Subjects to Evaluate the Effect of Rifampin on the Pharmacokinetics of IPI-145". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT01947777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*